EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 Expression

Yajun Zhang iD, Mingqin Zhou, Liwen Zhu iD, Lichan Chen iD, Haohua Zhang iD, Zhen Huang iD, Hongzhong Zhou

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s507656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yajun Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Liver Neoplasms, Tumor Necrosis Factor alpha-Induced Protein 3, NF-kappa B, Saponins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsTumor Necrosis Factor alpha-Induced Protein 3NF-kappa BSaponinsTriterpenesAntineoplastic Agents, PhytogenicHumansCell ProliferationAnimalsMiceDrug Screening Assays, AntitumorApoptosisDose-Response Relationship, DrugSignal TransductionTumor Cells, CulturedMice, NudeCell SurvivalStructure-Activity RelationshipMice, Inbred BALB C

Stichwörter der Autor:innen

NF-κBTNFAIP3hepatocellular carcinomaproliferationtubeimoside-I

Substanzen

Tumor Necrosis Factor alpha-Induced Protein 3NF-kappa BTNFAIP3 protein, humantubeimoside ISaponinsTriterpenesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Department of Critical Care Medicine, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
  • Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Medical Innovation Technology Transformation Cent…
  • Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Department of Laboratory Medicine of Pingshan District Maternal and Child Healthcare Hospital, Shenzhen, People's Republic of China.

ORCID-Profile: Yajun Zhang, Liwen Zhu, Lichan Chen, Haohua Zhang, Zhen Huang

Zitieren

APA

Zhang, Y., Zhou, M., Zhu, L., Chen, L., Zhang, H., Huang, Z., & Zhou, H. (2025). Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 Expression. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s507656

Vancouver

Zhang Y, Zhou M, Zhu L, Chen L, Zhang H, Huang Z, et al. Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 Expression. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s507656

BibTeX
@article{Zhang2025,
  author = {Zhang, Yajun and Zhou, Mingqin and Zhu, Liwen and Chen, Lichan and Zhang, Haohua and Huang, Zhen and Zhou, Hongzhong},
  title = {Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 Expression},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s507656}
}
Kostenlos starten →